Why OneMedNet Stock Is Soaring

OneMedNet Corp ONMD shares are trading higher Thursday after the company announced it has entered into a three-year Master Services Agreement with a medical technology company.

The Details:

OneMedNet said it has entered into a non-exclusive three-year Master Services Agreement (MSA) with an undisclosed U.S.-based medical technology company that affects more than 150 million patients worldwide annually.

Pursuant to the MSA, OneMedNet will utilize its iRWD platform to de-identify, search and curate current, regulatory-grade clinical data for the new customer, including its world-wide subsidiaries and affiliates, under a pre-established fee-for-service model.

Related News: UiPath Stock Plummets After Q1 Results: Here’s Why

“As medical device companies increasingly look to leverage the use of existing RWD, particularly medical imaging data, across many stages of development, from ideation up to and including post-market surveillance, there is growing industry awareness and adoption of our highly differentiated iRWD™ platform,” said Aaron Green, OneMedNet’s President and CEO.

“By providing timely access to de-identified and hard-to-curate current clinical information to this global medical technology industry leader, our aim is to not only provide it with comprehensive, accurate, and much needed patient information, but also help improve its competitive positioning by enabling it better informed decision-making.”

Should I Sell My ONMD Stock?

Whether to sell or hold a stock largely depends on an investor's strategy and risk tolerance. Swing traders may sell an outperforming stock to lock in a capital gain, while long-term investors might ride out the turbulence in anticipation of further share price growth.

Similarly, traders willing to minimize losses may sell a stock that falls a certain percentage, while long-term investors may see this as an opportunity to buy more shares at a discounted price.

Shares of OneMedNet have lost 71.95% year to date. This compares to the average annual return of -41.82%, meaning the stock has underperformed its historical averages. Investors can compare a stock's movement to its historical performance to gauge whether this is a normal movement or a potential trading opportunity.

Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. OneMedNet stock currently has an RSI of 79.7, indicating overbought conditions.

For analysis tools, charting data and access to exclusive stock news, check out Benzinga PRO. Try it for free.

ONMD Price Action: According to Benzinga Pro, OneMedNet shares are up 27.2% at $2.48 at the time of publication Thursday.

Image: Shutterstock